The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.225
Bid: 1.15
Ask: 1.30
Change: -0.025 (-2.00%)
Spread: 0.15 (13.043%)
Open: 1.25
High: 1.25
Low: 1.225
Prev. Close: 1.25
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update

16 Dec 2022 13:49

RNS Number : 0467K
Chamberlin PLC
16 December 2022
 

 

16 December 2022

Chamberlin plc

("Chamberlin", the "Company" or the "Group")

 

Corporate Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, announces the following corporate update.

 

Headlines

 

· Russell Ductile Castings returns best ever monthly performance, exceeding £1 million monthly revenue for the first time, in November 2022

· Investment in new plant and equipment at RDC now complete

· Group defined benefit pension scheme now in a surplus position

 

Russell Ductile Castings ("RDC")

  

As previously announced, RDC, the Group's Scunthorpe based foundry and the UK's leading provider of large, technically challenging Cast Iron products, has now completed a programme of investment in new plant and equipment which strengthens its position as a key supplier to the renewable offshore energy, energy generation and construction industries.

 

This investment is a key milestone for RDC and positions the business as the UKs largest foundry to provide castings ranging from 100kg to 7000kg, increasing RDC's ability to produce large castings over three tons by around 30%. The rapidly growing trend for localised supply chains and manufacturing re-shoring, coupled with RDC's focus on the renewable energy market, has seen orders books reach record levels in the last 12 months.

 

Pleasingly, RDC exceeded £1.0 million of revenue in November 2022 for the first time and reported an order book of around £4.0 million, remaining on track to deliver to the Board's expectations. This strong financial performance, along with a strong sales enquiry pipeline of approximately £17 million, underpins the decision to make the investment and capitalise on market opportunities.

 

Group Pension Scheme

 

The Group has one defined benefit pension scheme, which is closed to future accrual. As reported in the Company's Final Results in November 2022, the defined benefit pension scheme moved from a liability position of £1.2 million at 31 May 2021 to a £0.1 million surplus at 31 May 2022, as reduced liabilities arising from an increase in bond yields and Group contributions of £0.9 million more than offset a reduction in the market value of scheme assets.

 

The triennial valuation as at 31 March 2022 is currently in progress and the Company has appointed BDO UK LLP to advise the Chamberlin Board. The Company is seeking to ensure that current market conditions, the Group's improved covenant strength and the significant one-off payment of £0.6 million made in May 2022 from the RDC property sale and leaseback, are fully reflected in the new deficit valuation and any subsequent recovery plan payments required by the Company. This gives the Board confidence of a positive outcome and the ability to ensure that any ongoing deficit is minimised.

 

Enquiries:

 

Chamberlin plc

Kevin Price, Chief Executive

Alan Tomlinson, Finance Director

 

T: 01922 707100

 

 Cenkos Securities plc (Nominated Adviser and Broker)

Katy Birkin

Stephen Keys

George Lawson

 

T: 020 7397 8900

Peterhouse Capital Limited (Joint Broker)

Lucy Williams

Duncan Vasey

T: 020 7469 0930

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRATFBJTMTIBBRT
Date   Source Headline
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.